Article
A synergy of activity, stability, and inhibitor-interaction of HIV-1 protease mutants evolved under drug-pressure.
Protein science : a publication of the Protein Society - 1 Mar 2021
Khan Shahid N, Persons John D, Guerrero Michel, Ilina Tatiana V, Oda Masayuki, Ishima Rieko
Abstract excerpt
A clinically-relevant, drug-resistant mutant of HIV-1 protease (PR), termed Flap+(I54V) and containing L10I, G48V, I54V and V82A mutations, is known to produce significant changes in the entropy and enthalpy balance of drug-PR interactions, compared to wild-type PR. A similar mutant, Flap+(I54A) , which evolves from Flap+(I54V) and contains the single change at residue 54 relative to Flap+(I54V) , does not. Yet,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
